| Announce Date | 01/27/2026 |
| EPS Normalized Actual | $-0.48033 (Miss by $-0.03033) |
| EPS GAAP Actual | $-0.48033 (Miss by $-0.03033) |
| Revenue Actual | $2.244B |
| Revenue Surprise | Beat by $2244M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.33 |
| EPS GAAP Estimate | $-0.33 |
| Revenue Estimate | $2.5642627B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0.42 | 14.31 | 0.4113 | 0.43048 | 1 |
| Dec 2027 | 0.85 | 7.07 | 0.82774 | 0.87691 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -0.48 | -0.453 | 2.244B | -1.47% | -331.4M |
| FQ3 2025 (Sep 2025) | -0.39 | -0.51375 | 2.322B | -1.85% | -291.1M |
| FQ2 2025 (Jun 2025) | -0.21 | -0.48905 | 2.356B | -3.06% | -377.97M |
| FQ1 2025 (Mar 2025) | -0.59 | -0.2668 | 2.14B | -3.22% | -252.82M |
| FQ4 2024 (Dec 2024) | -0.13 | -0.13 | 2.277B | -2.11% | 2277M |
| FQ3 2024 (Sep 2024) | -0.17 | -0.17 | 2.365B | 0.51% | 2365M |
| FQ2 2024 (Jun 2024) | 0.07 | 0.07 | 2.428B | -7.5% | 2428M |
| FQ1 2024 (Mar 2024) | -2.11 | -2.11 | 2.209B | -5.39% | 2209M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.33
Consensus Revenue Estimates
2.5642627B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 0.0515 | -- | 0.05047823 | 0.05270752 | 3 |
| FQ2 2027 (Jun 2027) | 0.16 | -- | 0.15683 | 0.16375 | 5 |
| FQ1 2027 (Mar 2027) | -0.3415 | -- | -0.34951 | -0.33472 | 3 |
| FQ4 2026 (Oct 2026) | -0.19 | -152.63 | -0.19744 | -0.18471 | 3 |
| FQ3 2026 (Jul 2026) | -0.1 | -290 | -0.10392 | -0.09721338 | 5 |
| FQ2 2026 (Jun 2026) | 0.3497 | 160.05 | 0.33735 | 0.35914 | 5 |
| FQ1 2026 (Mar 2026) | -0.33 | -78.79 | -0.33891 | -0.31835 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 3.96B | -- | 3.9B | 4.03B | 3 |
| FQ2 2027 (Jun 2027) | 3.65B | -- | 3.59B | 3.72B | 3 |
| FQ1 2027 (Mar 2027) | 3.37B | -- | 3.31B | 3.43B | 3 |
| FQ4 2026 (Oct 2026) | 2.63B | 14.57 | 2.57B | 2.71B | 4 |
| FQ3 2026 (Jul 2026) | 2.63B | 11.63 | 2.57B | 2.71B | 5 |
| FQ2 2026 (Jun 2026) | 2.91B | 18.91 | 2.83B | 2.97B | 6 |
| FQ1 2026 (Mar 2026) | 2.56B | 16.55 | 2.49B | 2.62B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -0.027 | -0.48 | -0.453 | 94.38% |
| FQ3 2025 (Sep 2025) | 0.12375 | -0.39 | -0.51375 | 131.73% |
| FQ2 2025 (Jun 2025) | 0.27905 | -0.21 | -0.48905 | 232.88% |
| FQ1 2025 (Mar 2025) | -0.3232 | -0.59 | -0.2668 | 45.22% |
| FQ4 2024 (Dec 2024) | -0.13 | -0.13 | 100% | |
| FQ3 2024 (Sep 2024) | -0.17 | -0.17 | 100% | |
| FQ2 2024 (Jun 2024) | 0.07 | 0.07 | 100% | |
| FQ1 2024 (Mar 2024) | -2.11 | -2.11 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $2.58B | $2.24B | $-331.4M | -14.77% |
| FQ3 2025 (Sep 2025) | $2.61B | $2.32B | $-291.1M | -12.54% |
| FQ2 2025 (Jun 2025) | $2.73B | $2.36B | $-377.97M | -16.04% |
| FQ1 2025 (Mar 2025) | $2.39B | $2.14B | $-252.82M | -11.81% |
| FQ4 2024 (Dec 2024) | $0B | $2.28B | $2277M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.37B | $2365M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.43B | $2428M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.21B | $2209M | 100% |